The University of Chicago Header Logo

Connection

David T. Rubin to Liver Function Tests

Back to Details
This is a "connection" page, showing publications David T. Rubin has written about Liver Function Tests.
David T. Rubin
Connection Strength
0.158
Liver Function Tests
  1. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762.
    View in: PubMed
    Score: 0.158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.